by The non-invasive aesthetic treatment market size is predicted to reach USD 150.6 billion by 2030 and is expected to register a CAGR of 12.4% from 2022 to 2030.
The study provides an analysis of the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
The market revenue/volume with the help of widespread quantitative and qualitative insights, and forecasts of the market. This report presents a breakdown of the market into forthcoming and niche segments. Additionally, this research study gauges market revenue growth and its drift in global, regional, and country from 2017 to 2030.
The global non-invasive aesthetic treatment market is primarily driven by the rising demand for the skin aging treatment among the aging population. Moreover various skin related issues among the young population also drives the growth of the market. The technological advancements in the plastic surgery and the skin treatment procedures has resulted in the growth of the market. Moreover, the rising adoption of the non-invasive aesthetic treatments among the aging women population is significantly driving the growth of the global market.
Download a Free Sample Copy of this Report@ https://www.precedenceresearch.com/sample/1495
The women population aged 50 years and above is increasingly opting for Botox shots and fillers to enhance their physical appearance and conceal skin aging. The aesthetic appearances has gained much more importance in today’s world of social media and glamour. The beauty consciousness has increased tremendously among the teens, young adults, and the aging population across the globe, which significantly drives the growth of the global non-invasive aesthetic treatment market.
Table of Contents
Scope of the Non Invasive Aesthetic Treatment Market
| Report Coverage | Details |
| Market Size In 2021 | USD 52.57 Billion |
| Growth Rate from 2021 to 2030 | 12.4% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product, End Use, Region |
Market Dynamics
Driver
Increasing demand for the Botox injections
The increasing adoption of the Botox injections among the consumers for the aesthetic treatments especially among the old age population is expected to drive the non-invasive aesthetic treatment market during the forecast period. According to the American Society of Plastic Surgeons, an increase of about 845% was witnessed in the consumption of Botox injections within a time period of 18 years, from 2000 to 2018, in US.
Restraint
High cost of the treatment
The acquisition of advanced non-invasive aesthetic treatment procedures involves a high cost. This high cost of the procedures may restrict the demand among the low and the middle income consumers especially in the underdeveloped and developing countries.
Opportunity
Developmental strategies adopted by the market players
There are various developmental strategies like new product launches and collaborations that helps to spread awareness among the consumers regarding new procedures and products. For instance, in January 2021, Galderma introduced a program called Face for Change in association with The Skin Cancer Foundation and Dress for Success in US.
Challenge
Risks and complications associated with the treatment
The clinical procedures whether invasive or non-invasive are subject to certain level of risks and complications that may have a harmful impact on the skin or health of the consumers. This associated risks and complications are the major factors that may restrict the consumers to avoid such aesthetic treatments.
Report Highlights
- Based on the product, the injectable segment accounted for over 60% of the market share and dominated the global non-invasive aesthetic treatment market. The increased adoption of Botox injections and fillers especially among the aging women population has propelled the growth of this segment in the past decade.
- Based on the end use, the medical spa was the most dominant segment in 2020 that accounted for a market share of around 40%. This is attributable to the rising number of government approved medical spa and the professional surgeons across the developed and the developing markets like US, Japan, India, and China.
Read Also: Wind Energy Market Size to Gain US$ 174.75 Billion by 2030
Regional Snapshot
North America dominated the global non-invasive aesthetic treatment market and accounted for a market share of more than 36% in 2020. US is the largest market in North America and across the globe. According to the International Society of Aesthetic Plastic Surgery, US is the leading market for the non-invasive surgical procedures. Moreover, the increased adoption of injectables like Botox shots has significantly propelled the market growth.
The increased awareness regarding the availability of various types of non-invasive aesthetic treatment coupled with increased beauty consciousness and high disposable income are the major market drivers in North America. Furthermore, the presence of adequate number of efficient and experienced surgeons has great contributions in the increased adoption of the aesthetic treatments in the region. According to the International Society of Aesthetic Plastic Surgery, there were around 7,000 plastic surgeons in US as of 2019.
On the other hand, Asia Pacific is estimated to be the fastest-growing market. The rising awareness among the people regarding the non-invasive aesthetic treatment, rising disposable income, presence of huge young population, and rapidly growing geriatric population in the region are some of the prominent factors contributing towards the growth of the market. According to the United Nations, around 80% of the global old age population will be living in the low and the middle income countries by 2050. Furthermore, rising penetration of the medical spas across the developing countries like China, India, Japan, South Korea, and Thailand is significantly boosting the growth of the Asia Pacific non-invasive aesthetic treatment market.
The prominent market players operating in the market includes:
- Galderma S.A.
- Allergen
- El. En. SpA
- Alma Lasers
- Johnson & Johnson
- Cynosure
- Solta Medical
- Syneron Candela
- Lumenis
- Merz Pharma
Segments Covered in the Report
By Product
- Injectable
- Polymer Filler
- Collagen
- Botulinum Toxin
- Hyaluronic Acid
- Calcium Hydroxylapatite
- Skin Rejuvenation
- Laser Skin Resurfacing
- Chemical Peel
- Photo-rejuvenation
- Others
- Hair Removal
- Sclerotherapy
- Non-surgical Fat reduction
- Cellulite Treatment
By End Use
- Hospitals & Surgery Centers
- Medical Spa
- Traditional Spa
- HCP Owned Clinic
- Others
By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
Key Points Covered in non-invasive aesthetic treatment market Study:
- Growth of non-invasive aesthetic treatment in 2022
- Market Estimates and Forecasts (2017-2030)
- Market Share Analysis
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Recommendation on Key Winning Strategies
- COVID-19 Impact on Demand for non-invasive aesthetic treatment and How to Navigate
- Key Product Innovations and Regulatory Climate
- Consumption Analysis
- Production Analysis
- Market and Management
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Non-Invasive Aesthetic Treatment Market
5.1. COVID-19 Landscape: Non-Invasive Aesthetic Treatment Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Non-Invasive Aesthetic Treatment Market, By Product
8.1. Non-Invasive Aesthetic Treatment Market, by Product Type, 2021-2030
8.1.1. Injectable
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Skin Rejuvenation
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Non-Invasive Aesthetic Treatment Market, By End Use
9.1. Non-Invasive Aesthetic Treatment Market, by End Use, 2021-2030
9.1.1. Hospitals & Surgery Centers
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Medical Spa
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Clinics
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Non-Invasive Aesthetic Treatment Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.2. Market Revenue and Forecast, by End Use (2019-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.3.2. Market Revenue and Forecast, by End Use (2019-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.4.2. Market Revenue and Forecast, by End Use (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.2. Market Revenue and Forecast, by End Use (2019-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.3.2. Market Revenue and Forecast, by End Use (2019-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.4.2. Market Revenue and Forecast, by End Use (2019-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.5.2. Market Revenue and Forecast, by End Use (2019-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.6.2. Market Revenue and Forecast, by End Use (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.2. Market Revenue and Forecast, by End Use (2019-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.3.2. Market Revenue and Forecast, by End Use (2019-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.4.2. Market Revenue and Forecast, by End Use (2019-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.5.2. Market Revenue and Forecast, by End Use (2019-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.6.2. Market Revenue and Forecast, by End Use (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.2. Market Revenue and Forecast, by End Use (2019-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.3.2. Market Revenue and Forecast, by End Use (2019-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.4.2. Market Revenue and Forecast, by End Use (2019-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.5.2. Market Revenue and Forecast, by End Use (2019-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.6.2. Market Revenue and Forecast, by End Use (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.2. Market Revenue and Forecast, by End Use (2019-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.3.2. Market Revenue and Forecast, by End Use (2019-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.4.2. Market Revenue and Forecast, by End Use (2019-2030)
Chapter 11. Company Profiles
11.1. Galderma S.A.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Allergen
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. El. En. SpA
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Alma Lasers
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Johnson & Johnson
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Cynosure
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Solta Medical
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Syneron Candela
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Lumenis
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Merz Pharma
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1495
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
